European Union-Funded Research on Microdosing LSD's Impact on Mental Health
Published on 4.20.25
Mental health has become a pressing concern globally, with various approaches being explored to address its complexities. In recent years, microdosing, which involves taking small amounts of psychedelic substances such as LSD or psilocybin, has gained attention for its potential benefits in treating mild depression and anxiety.
The European Union is funding research into microdosing LSD, with studies being conducted by University of Chicago researcher Harriet de Wit and others. Balazs Szigeti of the University of California, San Francisco, suggests that microdosing may harness the placebo effect to provide personal benefits. While some small trials have shown promise, more research is needed to fully understand the effects of microdosing on mental health.
The Fireside Project offers phone support for individuals experiencing microdosing-related issues. As policymakers and researchers continue to explore new approaches, it is essential to prioritize caution and ensure that any interventions are safe and effective.